PLSE
PLSE
NASDAQ · Health Care

Pulse Biosciences Inc

$53.07
-3.99 (-6.99%)
As of Nov 7, 1:49 AM ET ·
Financial Highlights (FY 2026)
Revenue
374.3K
Net Income
-77,727,384
Gross Margin
-54.0%
Profit Margin
-20,794.6%
Rev Growth
-20.6%
D/E Ratio
—
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin -54.0% -54.0% 64.0% 64.0%
Operating Margin -21,982.6% -19,784.3% 8.7% 7.9%
Profit Margin -20,794.6% -19,754.8% 8.4% 7.9%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 374.3K 471.6K 720.89M 620.86M
Gross Profit -202,109 -254,641 461.24M 397.24M
Operating Income -82,275,703 -93,294,862 62.62M 49.27M
Net Income -77,727,384 -88,137,388 60.22M 48.91M
Gross Margin -54.0% -54.0% 64.0% 64.0%
Operating Margin -21,982.6% -19,784.3% 8.7% 7.9%
Profit Margin -20,794.6% -19,754.8% 8.4% 7.9%
Rev Growth -20.6% -20.6% -7.3% +13.8%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 0 0 308.01M 262.97M
Total Equity — — 738.41M 772.91M
D/E Ratio — — 0.42 0.34
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -81,736,473 -97,832,492 74.89M 60.65M
Free Cash Flow — — 49.96M 50.83M